MicroRNAs (miRNAs) are small, non-coding RNAs that are essential for the regulation of post-transcriptional gene expression during tissue development and differentiation. They are involved in the regulation of manifold metabolic and hormonal processes and, within the female reproductive tract, in oocyte maturation and folliculogenesis. Altered miRNA levels have been observed in oncological and inflammatory diseases, diabetes or polycystic ovary syndrome (PCOS). Therefore, miRNAs are proving to be promising potential biomarkers. In women with PCOS, circulating miRNAs can be obtained from whole blood, serum, plasma, urine, and follicular fluid. Our systematic review summarizes data from 2010-2021 on miRNA expression in granulosa and theca cells, the relationship between miRNAs, hormonal changes, glucose and lipid metabo-lism in women with PCOS, and the potential role of altered miRNAs in fertility (oocyte quality) in PCOS. Furthermore, we discuss miRNAs as a potential therapeutic target in PCOS and as a di-agnostic marker for PCOS.
The Translational Role of miRNA in Polycystic Ovary Syndrome: From Bench to Bedside. A Systematic Literature Review
Salvatore Giovanni Vitale;Anna Maria Fulghesu;Maurizio Nicola D'Alterio;Stefano Angioni
Ultimo
Writing – Review & Editing
2022-01-01
Abstract
MicroRNAs (miRNAs) are small, non-coding RNAs that are essential for the regulation of post-transcriptional gene expression during tissue development and differentiation. They are involved in the regulation of manifold metabolic and hormonal processes and, within the female reproductive tract, in oocyte maturation and folliculogenesis. Altered miRNA levels have been observed in oncological and inflammatory diseases, diabetes or polycystic ovary syndrome (PCOS). Therefore, miRNAs are proving to be promising potential biomarkers. In women with PCOS, circulating miRNAs can be obtained from whole blood, serum, plasma, urine, and follicular fluid. Our systematic review summarizes data from 2010-2021 on miRNA expression in granulosa and theca cells, the relationship between miRNAs, hormonal changes, glucose and lipid metabo-lism in women with PCOS, and the potential role of altered miRNAs in fertility (oocyte quality) in PCOS. Furthermore, we discuss miRNAs as a potential therapeutic target in PCOS and as a di-agnostic marker for PCOS.File | Dimensione | Formato | |
---|---|---|---|
Vitale Biomedicines 2022.pdf
accesso aperto
Tipologia:
versione editoriale (VoR)
Dimensione
5.53 MB
Formato
Adobe PDF
|
5.53 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.